Tuning Tissue Ingrowth into Proangiogenic Hydrogels via Dual Modality Degradation.

biomimetic material hydrogel hydrolysis matrix metalloproteinase tissue invasion

Journal

ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670

Informations de publication

Date de publication:
14 Oct 2019
Historique:
entrez: 19 1 2021
pubmed: 14 10 2019
medline: 14 10 2019
Statut: ppublish

Résumé

The potential to control the rate of replacement of a biodegradable implant by a tissue would be advantageous. Here, we demonstrate that tissue invasion can be tuned through the novel approach of overlaying an enzymatically degradable hydrogel with an increasingly hydrolytically degradable environment. Poly(ethylene glycol) (PEG) hydrogels were formed from varying proportions of PEG-vinyl sulfone and PEG-acrylate (PEG-AC) monomers via a Michael-type addition reaction with a dithiol-containing matrix-metalloproteinase-susceptible peptide cross-linker. Swelling studies showed that PEG hydrogels with similar initial stiffnesses degraded more rapidly as the PEG-AC content increased. The replacement of subcutaneously implanted PEG hydrogels was also found to be proportional to their PEG-AC content. In addition, it would in many instances be desirable that these materials have the ability to stimulate their neovascularization. These hydrogels contained covalently bound heparin, and it was shown that a formulation of the hydrogel that allowed tissue replacement to occur over 1 month could trap and release growth factors and increase neovascularization by 50% over that time.

Identifiants

pubmed: 33464063
doi: 10.1021/acsbiomaterials.9b01220
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5430-5438

Auteurs

Nikolaus Thierfelder (N)

Department of Cardiac Surgery, Ludwig-Maximilians University Munich, Leopoldstraße 13, 80802 Munich, Germany.

Federica Pisano (F)

Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Viale Camillo Golgi, 19, 27100 Pavia, Italy.

Manuela Mura (M)

Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Viale Camillo Golgi, 19, 27100 Pavia, Italy.

Massimiliano Gnecchi (M)

Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Viale Camillo Golgi, 19, 27100 Pavia, Italy.

Classifications MeSH